Glucoregulation in alloxan-diabetic dogs.

Area of Science:

• Endocrinology
• Metabolic Regulation
• Animal Models

Background:

• Prolonged subnormal insulin secretion can impact glucose homeostasis.
• Understanding glucoregulation in diabetes is crucial for managing blood sugar levels.

Purpose of the Study:

• To investigate if reduced insulin secretion affects glucose regulation during hypoglycemia in diabetic dogs.
• To assess the impact of prior insulin treatment on glucoregulatory responses.

Main Methods:

• Alloxan-diabetic dogs were subjected to hypoglycemia induced by phlorizin or insulin infusion.
• Plasma glucose, insulin (IRI), glucagon (IRG), and catecholamines were measured.
• Hepatic glucose production (Ra) and glucose removal rates were determined using tracer methods.

Main Results:

• Phlorizin-induced hypoglycemia in untreated diabetic dogs led to decreased plasma glucose but no significant increase in hepatic glucose production or epinephrine.
• Prior insulin treatment normalized plasma glucose and improved the insulin/glucagon ratio.
• In insulin-treated dogs, phlorizin infusion increased hepatic glucose production, indicating restored glucoregulation.

Conclusions:

• Subnormal insulin secretion impairs the counter-regulatory response to hypoglycemia in diabetic dogs.
• Short-term insulin treatment can restore normal glucose regulation and improve responses to hypoglycemic stimuli.